Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

por Walleser, Silke, Ray, Joshua, Bischoff, Helge, Vergnenègre, Alain, Rosery, Hubertus, Chouaid, Christos, Heigener, David, de Castro Carpeño, Javier, Tiseo, Marcello, Walzer, Stefan
Publicado 2012

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

por Campos‐Balea, Begoña, de Castro Carpeño, Javier, Massutí, Bartomeu, Vicente‐Baz, David, Pérez Parente, Diego, Ruiz‐Gracia, Pedro, Crama, Leonardo, Cobo Dols, Manuel
Publicado 2020

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors...

por Hurtado, Felipe K., de Braud, Filippo, De Castro Carpeño, Javier, de Miguel Luken, Maria Jose, Wang, Ding, Scott, Jeffrey, Lau, Yvonne Y., McCulloch, Tracey, Mau-Sorensen, Morten
Publicado 2021

Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer

por Montalbán-Hernández, Karla, Casalvilla-Dueñas, José Carlos, Cruz-Castellanos, Patricia, Gutierrez-Sainz, Laura, Lozano-Rodríguez, Roberto, Avendaño-Ortiz, José, del Fresno, Carlos, de Castro-Carpeño, Javier, López-Collazo, Eduardo
Publicado 2022

KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis

por Cejas, Paloma, López-Gómez, Miriam, Aguayo, Cristina, Madero, Rosario, de Castro Carpeño, Javier, Belda-Iniesta, Cristóbal, Barriuso, Jorge, Moreno García, Víctor, Larrauri, Javier, López, Rocío, Casado, Enrique, Gonzalez-Barón, Manuel, Feliu, Jaime
Publicado 2009

Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer

por Nadal, Ernest, Oré-Arce, Martín, Remon, Jordi, Bernabé-Caro, Reyes, Covela-Rúa, Marta, de Castro-Carpeño, Javier, Massutí-Sureda, Bartomeu, Guillot-Morales, Mónica, Majem, Margarita, Maestu-Maiques, Inmaculada, Morilla-Ruíz, Idoia, Gironés, Regina
Publicado 2023

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

por Lin, Chia-Chi, Arkenau, Hendrik-Tobias, Lu, Sharon, Sachdev, Jasgit, de Castro Carpeño, Javier, Mita, Monica, Dziadziuszko, Rafal, Su, Wu-Chou, Bobilev, Dmitri, Hughes, Lorraine, Chan, Jian, Zhang, Zhi-Yi, Weiss, Glen J.
Publicado 2019

PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis

por García Campelo, María Rosario, Arriola, Edurne, Campos Balea, Begoña, López-Brea, Marta, Fuentes-Pradera, José, de Castro Carpeno, Javier, Aguado, Carlos, Pérez Parente, Diego, de Oro Pulido, Fidel, Ruiz-Gracia, Pedro, Rodríguez-Abreu, Delvys
Publicado 2021

miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients

por Sanchez-Cabrero, Darío, Garcia-Guede, Álvaro, Burdiel, Miranda, Pernía, Olga, Colmenarejo-Fernandez, Julián, Gutierrez, Laura, Higuera, Oliver, Rodriguez, Isabel Esteban, Rosas-Alonso, Rocío, Rodriguez-Antolín, Carlos, Losantos-García, Itsaso, Vera, Olga, De Castro-Carpeño, Javier, Ibanez de Caceres, Inmaculada
Publicado 2023

Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy

por Guijarro-Eguinoa, Javier, Arjona-Hernandez, Sara, Stewart, Stefan, Pernia, Olga, Arias, Pedro, Losantos-García, Itsaso, Rubio, Tania, Burdiel, Miranda, Rodriguez-Antolin, Carlos, Cruz-Castellanos, Patricia, Higuera, Oliver, Borobia, Alberto M., Rodriguez-Novoa, Sonia, de Castro-Carpeño, Javier, Ibanez de Caceres, Inmaculada, Rosas-Alonso, Rocio
Publicado 2023

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

por Liu, Stephen V., Reck, Martin, Mansfield, Aaron S., Mok, Tony, Scherpereel, Arnaud, Reinmuth, Niels, Garassino, Marina Chiara, De Castro Carpeno, Javier, Califano, Raffaele, Nishio, Makoto, Orlandi, Francisco, Alatorre-Alexander, Jorge, Leal, Ticiana, Cheng, Ying, Lee, Jong-Seok, Lam, Sivuonthanh, McCleland, Mark, Deng, Yu, Phan, See, Horn, Leora
Publicado 2021

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

por Sierra-Rodero, Belén, Cruz-Bermúdez, Alberto, Nadal, Ernest, Garitaonaindía, Yago, Insa, Amelia, Mosquera, Joaquín, Casal-Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodriguez-Abreu, Delvys, Martinez-Marti, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Laza-Briviesca, Raquel, Casarrubios, Marta, García-Grande, Aránzazu, Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmu...

por Casarrubios, Marta, Provencio, Mariano, Nadal, Ernest, Insa, Amelia, del Rosario García-Campelo, María, Lázaro-Quintela, Martín, Dómine, Manuel, Majem, Margarita, Rodriguez-Abreu, Delvys, Martinez-Marti, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Massuti, Bartomeu, Sierra-Rodero, Belén, Martinez-Toledo, Cristina, Fernández-Miranda, Ismael, Serna-Blanco, Roberto, Romero, Atocha, Calvo, Virginia, Cruz-Bermúdez, Alberto
Publicado 2022

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

por Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E., Chow, Laura Q. M., Burgio, Marco Angelo, de Castro Carpeno, Javier, Pluzanski, Adam, Arrieta, Oscar, Frontera, Osvaldo Arén, Chiari, Rita, Butts, Charles, Wójcik-Tomaszewska, Joanna, Coudert, Bruno, Garassino, Marina Chiara, Ready, Neal, Felip, Enriqueta, García, Miriam Alonso, Waterhouse, David, Domine, Manuel, Barlesi, Fabrice, Antonia, Scott, Wohlleber, Markus, Gerber, David E., Czyzewicz, Grzegorz, Spigel, David R., Crino, Lucio, Eberhardt, Wilfried Enst Erich, Li, Ang, Marimuthu, Sathiya, Brahmer, Julie
Publicado 2021

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

por Laza‐Briviesca, Raquel, Cruz‐Bermúdez, Alberto, Nadal, Ernest, Insa, Amelia, García‐Campelo, María del Rosario, Huidobro, Gerardo, Dómine, Manuel, Majem, Margarita, Rodríguez‐Abreu, Delvys, Martínez‐Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Casarrubios, Marta, Sierra‐Rodero, Belén, Tarín, Carlos, García‐Grande, Aránzazu, Haymaker, Cara, Wistuba, Ignacio I., Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

por Provencio, Mariano, Serna-Blasco, Roberto, Nadal, Ernest, Insa, Amelia, García-Campelo, M. Rosario, Casal Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodríguez-Abreu, Delvys, Martínez-Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Pereira, Eva, Royuela, Ana, Calvo, Virginia, Martín-López, Javier, García-García, Francisco, Casarrubios, Marta, Franco, Fernando, Sánchez-Herrero, Estela, Massuti, Bartomeu, Cruz-Bermúdez, Alberto, Romero, Atocha
Publicado 2022

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

por Casarrubios, Marta, Cruz-Bermúdez, Alberto, Nadal, Ernest, Insa, Amelia, García Campelo, María del Rosario, Lázaro, Martín, Dómine, Manuel, Majem, Margarita, Rodríguez-Abreu, Delvys, Martínez-Martí, Alex, de Castro-Carpeño, Javier, Cobo, Manuel, López-Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Barquín, Miguel, Laza-Briviesca, Raquel, Sierra-Rodero, Belén, Parra, Edwin R., Sanchez-Espiridion, Beatriz, Rocha, Pedro, Kadara, Humam, Wistuba, Ignacio I., Romero, Atocha, Calvo, Virginia, Provencio, Mariano
Publicado 2021